Previous studies showed that miR‐223 could promote inflammatory damage in the CNS system by targeting ATG16L1,27 and that ATG16L1 has been shown to inhibit lung injury caused by infection by regulating the expression of IL‐22 or IFN.28 The gene discussed is ATG16L1; the disease is infection.